NATIONAL BANK OF CANADA /FI/ - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$15,900
-13.8%
2,5000.0%0.00%
Q1 2023$18,450
+70.0%
2,5000.0%0.00%
Q4 2022$10,850
-89.5%
2,500
-86.0%
0.00%
Q2 2022$103,000
-93.5%
17,800
-88.7%
0.00%
-100.0%
Q1 2022$1,591,000
+541.5%
156,900
+424.7%
0.01%
+400.0%
Q4 2021$248,00029,9000.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders